section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

I

Aminophylline

(Mfr: AMR)(Conc: 1 mg/mLa)

Remarks:

Haze or precipitate forms immediately

Ref:

2928